Veracyte (VCYT) EPS (Basic) (2012 - 2026)

Veracyte has disclosed EPS (Basic) across 15 years of filings, most recently posting $0.36 for Q1 2026.

• EPS (Basic) for Q1 2026 came in at $0.36, up 300.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.11 (up 158.14% YoY), and the FY2025 annual result was $0.84, up 162.5% from the prior year.
• EPS (Basic) came in at $0.36 for Q1 2026 at Veracyte, down from $0.52 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $0.52 in Q4 2025 to a low of -$0.41 in Q3 2023.
• The 5-year median for EPS (Basic) is -$0.02 (2024), against an average of $0.0.
• Across the five-year window, EPS (Basic) sank 660.0% in 2023 and jumped 642.86% in 2025, its largest moves.
• Veracyte's EPS (Basic) stood at -$0.05 in 2022, then tumbled by 660.0% to -$0.38 in 2023, then jumped by 118.42% to $0.07 in 2024, then surged by 642.86% to $0.52 in 2025, then sank by 30.77% to $0.36 in 2026.
• The last three EPS (Basic) figures came in at $0.36 (Q1 2026), $0.52 (Q4 2025), and $0.24 (Q3 2025), per Business Quant data.